ERDAFITINIB 3 mg (Erdanat) x 28 Tablets

Uses of ERDAFITINIB 3 mg

• Treats FGFR-altered urothelial (bladder) cancer
• Used for locally advanced or metastatic disease
• Helps slow cancer progression
• Used after certain previous treatments when appropriate
• Part of targeted cancer therapy

Benefits

• Targets cancer cells with FGFR alterations
• Slows tumour growth
• Helps delay disease progression
• May improve treatment outcomes
• Convenient oral treatment

How Does ERDAFITINIB Work?

Erdafitinib is an FGFR (fibroblast growth factor receptor) inhibitor. It blocks abnormal FGFR proteins that send growth signals to cancer cells. By inhibiting these signals, it helps slow the growth, multiplication, and spread of cancer cells.

Side Effects

• Mouth sores
• Dry mouth
• Diarrhoea
• Fatigue
• Nail changes
• Dry skin
• Increased phosphate levels
• Eye or vision problems

Precautions

• Take the medicine exactly as prescribed.
• Have regular eye examinations during treatment.
• Monitor blood phosphate levels as advised by your doctor.
• Inform your doctor about any vision changes immediately.
• Tell your healthcare provider about all medicines and supplements you are taking.
• Avoid pregnancy during treatment and use effective contraception if advised.
• Attend regular follow-up visits and blood tests to monitor your response to treatment.